These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 9892908)

  • 1. Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy.
    Kragballe K; Barnes L; Hamberg KJ; Hutchinson P; Murphy F; Møller S; Ruzicka T; Van De Kerkhof PC
    Br J Dermatol; 1998 Oct; 139(4):649-54. PubMed ID: 9892908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
    Glade CP; Van Erp PE; Van De Kerkhof PC
    Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    Molin L; Cutler TP; Helander I; Nyfors B; Downes N
    Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial.
    Guenther L; Van de Kerkhof PC; Snellman E; Kragballe K; Chu AC; Tegner E; Garcia-Diez A; Springborg J
    Br J Dermatol; 2002 Aug; 147(2):316-23. PubMed ID: 12174105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study.
    Ruzicka T; Lorenz B
    Br J Dermatol; 1998 Feb; 138(2):254-8. PubMed ID: 9602870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol.
    Cassano N; Miracapillo A; Coviello C; Loconsole F; Bellino M; Vena GA
    Clin Drug Investig; 2006; 26(4):227-33. PubMed ID: 17163256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris.
    Kragballe K; Gjertsen BT; De Hoop D; Karlsmark T; van de Kerkhof PC; Larkö O; Nieboer C; Roed-Petersen J; Strand A; Tikjøb G
    Lancet; 1991 Jan; 337(8735):193-6. PubMed ID: 1670840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion.
    Duweb GA; Abuzariba O; Rahim M; al-Taweel M; Abdulla SA
    Int J Clin Pharmacol Res; 2000; 20(3-4):65-8. PubMed ID: 11314240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
    Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
    Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, placebo-controlled, randomized, right-left study comparing calcipotriol monotherapy with a combined treatment of calcipotriol and diflucortolone valerate in chronic plaque psoriasis.
    Salmhofer W; Maier H; Soyer HP; Hönigsmann H; Hödl S
    Acta Derm Venereol Suppl (Stockh); 2000; (211):5-8. PubMed ID: 11234559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcipotriol ointment. A review of its use in the management of psoriasis.
    Scott LJ; Dunn CJ; Goa KL
    Am J Clin Dermatol; 2001; 2(2):95-120. PubMed ID: 11705309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
    van de Kerkhof PC
    Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of calcipotriol solution (50 micrograms/ml) and betamethasone 17-valerate solution (1 mg/ml) in the treatment of scalp psoriasis.
    Klaber MR; Hutchinson PE; Pedvis-Leftick A; Kragballe K; Reunala TL; Van de Kerkhof PC; Johnsson MK; Molin L; Corbett MS; Downess N
    Br J Dermatol; 1994 Nov; 131(5):678-83. PubMed ID: 7999600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study.
    Thaçi D; Ortonne JP; Chimenti S; Ghislain PD; Arenberger P; Kragballe K; Saurat JH; Khemis A; Sprøgel P; Esslinger HU; Unnebrink K; Kupper H
    Br J Dermatol; 2010 Aug; 163(2):402-11. PubMed ID: 20377585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris.
    Cunliffe WJ; Berth-Jones J; Claudy A; Fairiss G; Goldin D; Gratton D; Henderson CA; Holden CA; Maddin WS; Ortonne JP
    J Am Acad Dermatol; 1992 May; 26(5 Pt 1):736-43. PubMed ID: 1583173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial.
    Xia L; Li R; Wang Y; Lin Z; Zheng J; Li X; Lu Q; Zhang J; Jin H; Fu L; Zhang X; Liu Y; Yang S; Xiao F; Gao XH
    Dermatol Ther; 2018 Sep; 31(5):e12632. PubMed ID: 30253049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcipotriol cream: a review of its use in the management of psoriasis.
    Segaert S; Duvold LB
    J Dermatolog Treat; 2006; 17(6):327-37. PubMed ID: 17853305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid.
    Tosti A; Piraccini BM; Cameli N; Kokely F; Plozzer C; Cannata GE; Benelli C
    Br J Dermatol; 1998 Oct; 139(4):655-9. PubMed ID: 9892909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoconstrictor potency of fixed-dose combination calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) cutaneous foam versus other topical corticosteroids used to treat psoriasis vulgaris.
    Queille-Roussel C; Nielsen J; Lacour JP
    J Dermatolog Treat; 2019 Sep; 30(6):529-533. PubMed ID: 30582717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.